Europe Apixaban Market Research Report Forecast 2017-2021

June 2017 | 124 pages | ID: E3A19160826EN
S&P Consulting

Abstracts

The Europe Apixaban Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Apixaban industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Apixaban market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Apixaban Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Pfizer, Inc. (US)
Bayer Healthcare AG (Germany)
GlaxoSmithKline Plc. (UK)
Boehringer Ingelheim (Germany)
Sanofi S.A. (France)
Abbott India Limited (India)
Aspen Holdings (South Africa)
Bristol-Myers Squibb Company (US)
Eisai Inc. (US)

Europe Apixaban Market Analysis by Product

• Type 1
• Type 2
• Type 3

Europe Apixaban Market Analysis by Application

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 APIXABAN MARKET OVERVIEW

1.1 Product Overview and Scope of Apixaban
1.2 Classification of Apixaban
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Apixaban
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Apixaban Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Apixaban (2012-2021)
  1.5.1 Europe Apixaban Sales and Growth Rate (2012-2021)
  1.5.2 Europe Apixaban Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON APIXABAN INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 APIXABAN MANUFACTURING COST ANALYSIS

3.1 Apixaban Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Apixaban

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Apixaban Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Apixaban Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE APIXABAN MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Apixaban Market Competition by Manufacturers
  5.1.1 Europe Apixaban Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Apixaban Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Apixaban (Volume and Value) by Type
  5.2.1 Europe Apixaban Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Apixaban Revenue and Market Share by Type (2012-2017)
5.3 Europe Apixaban (Volume and Value) by Countries
  5.3.1 Europe Apixaban Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Apixaban Revenue and Market Share by Countries (2012-2017)
5.4 Europe Apixaban (Volume) by Application

6 GERMANY APIXABAN (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Apixaban Sales and Value (2012-2017)
  6.1.1 Germany Apixaban Sales and Growth Rate (2012-2017)
  6.1.2 Germany Apixaban Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Apixaban Sales Price Trend (2012-2017)
6.2 Germany Apixaban Sales and Market Share by Manufacturers
6.3 Germany Apixaban Sales and Market Share by Type
6.4 Germany Apixaban Sales and Market Share by Application

7 FRANCE APIXABAN (VOLUME, VALUE AND SALES PRICE)

7.1 France Apixaban Sales and Value (2012-2017)
  7.1.1 France Apixaban Sales and Growth Rate (2012-2017)
  7.1.2 France Apixaban Revenue and Growth Rate (2012-2017)
  7.1.3 France Apixaban Sales Price Trend (2012-2017)
7.2 France Apixaban Sales and Market Share by Manufacturers
7.3 France Apixaban Sales and Market Share by Type
7.4 France Apixaban Sales and Market Share by Application

8 UK APIXABAN (VOLUME, VALUE AND SALES PRICE)

8.1 UK Apixaban Sales and Value (2012-2017)
  8.1.1 UK Apixaban Sales and Growth Rate (2012-2017)
  8.1.2 UK Apixaban Revenue and Growth Rate (2012-2017)
  8.1.3 UK Apixaban Sales Price Trend (2012-2017)
8.2 UK Apixaban Sales and Market Share by Manufacturers
8.3 UK Apixaban Sales and Market Share by Type
8.4 UK Apixaban Sales and Market Share by Application

9 RUSSIA APIXABAN (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Apixaban Sales and Value (2012-2017)
  9.1.1 Russia Apixaban Sales and Growth Rate (2012-2017)
  9.1.2 Russia Apixaban Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Apixaban Sales Price Trend (2012-2017)
9.2 Russia Apixaban Sales and Market Share by Manufacturers
9.3 Russia Apixaban Sales and Market Share by Type
9.4 Russia Apixaban Sales and Market Share by Application

10 ITALY APIXABAN (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Apixaban Sales and Value (2012-2017)
  10.1.1 Italy Apixaban Sales and Growth Rate (2012-2017)
  10.1.2 Italy Apixaban Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Apixaban Sales Price Trend (2012-2017)
10.2 Italy Apixaban Sales and Market Share by Manufacturers
10.3 Italy Apixaban Sales and Market Share by Type
10.4 Italy Apixaban Sales and Market Share by Application

11 SPAIN APIXABAN (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Apixaban Sales and Value (2012-2017)
  11.1.1 Spain Apixaban Sales and Growth Rate (2012-2017)
  11.1.2 Spain Apixaban Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Apixaban Sales Price Trend (2012-2017)
11.2 Spain Apixaban Sales and Market Share by Manufacturers
11.3 Spain Apixaban Sales and Market Share by Type
11.4 Spain Apixaban Sales and Market Share by Application

12 BENELUX APIXABAN (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Apixaban Sales and Value (2012-2017)
  12.1.1 Benelux Apixaban Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Apixaban Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Apixaban Sales Price Trend (2012-2017)
12.2 Benelux Apixaban Sales and Market Share by Manufacturers
12.3 Benelux Apixaban Sales and Market Share by Type
12.4 Benelux Apixaban Sales and Market Share by Application

13 EUROPE APIXABAN MANUFACTURERS ANALYSIS

13.1 Pfizer, Inc. (US)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Bayer Healthcare AG (Germany)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 GlaxoSmithKline Plc. (UK)
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Boehringer Ingelheim (Germany)
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Sanofi S.A. (France)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Abbott India Limited (India)
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Aspen Holdings (South Africa)
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Bristol-Myers Squibb Company (US)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Eisai Inc. (US)
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE APIXABAN MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Apixaban Market Forecast by Type (2017-2021)
15.9 Europe Apixaban Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Apixaban
Table Classification of Apixaban
Figure Europe Sales Market Share of Apixaban by Type in 2015
Table Application of Apixaban
Figure Europe Sales Market Share of Apixaban by Application in 2015
Figure Germany Apixaban Revenue and Growth Rate (2012-2021)
Figure France Apixaban Revenue and Growth Rate (2012-2021)
Figure UK Apixaban Revenue and Growth Rate (2012-2021)
Figure Russia Apixaban Revenue and Growth Rate (2012-2021)
Figure Italy Apixaban Revenue and Growth Rate (2012-2021)
Figure Spain Apixaban Revenue and Growth Rate (2012-2021)
Figure Benelux Apixaban Revenue and Growth Rate (2012-2021)
Figure Europe Apixaban Sales and Growth Rate (2012-2021)
Figure Europe Apixaban Revenue and Growth Rate (2012-2021)
Table Europe Apixaban Sales of Key Manufacturers (2015 and 2016)
Table Europe Apixaban Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Apixaban Sales Share by Manufacturers
Figure 2016 Apixaban Sales Share by Manufacturers
Table Europe Apixaban Revenue by Manufacturers (2015 and 2016)
Table Europe Apixaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Apixaban Revenue Share by Manufacturers
Table 2016 Europe Apixaban Revenue Share by Manufacturers
Table Europe Apixaban Sales and Market Share by Type (2012-2017)
Table Europe Apixaban Sales Share by Type (2012-2017)
Figure Sales Market Share of Apixaban by Type (2012-2017)
Figure Europe Apixaban Sales Growth Rate by Type (2012-2017)
Table Europe Apixaban Revenue and Market Share by Type (2012-2017)
Table Europe Apixaban Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Apixaban by Type (2012-2017)
Figure Europe Apixaban Revenue Growth Rate by Type (2012-2017)
Table Europe Apixaban Sales and Market Share by Countries (2012-2017)
Table Europe Apixaban Sales Share by Countries (2012-2017)
Figure Sales Market Share of Apixaban by Countries (2012-2017)
Table Europe Apixaban Revenue and Market Share by Countries (2012-2017)
Table Europe Apixaban Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Apixaban by Countries (2012-2017)
Table Europe Apixaban Sales and Market Share by Application (2012-2017)
Table Europe Apixaban Sales Share by Application (2012-2017)
Figure Sales Market Share of Apixaban by Application (2012-2017)
Figure Germany Apixaban Sales and Growth Rate (2012-2017)
Figure Germany Apixaban Revenue and Growth Rate (2012-2017)
Figure Germany Apixaban Sales Price Trend (2012-2017)
Table Germany Apixaban Sales by Manufacturers (2015 and 2016)
Table Germany Apixaban Market Share by Manufacturers (2015 and 2016)
Table Germany Apixaban Sales by Type (2015 and 2016)
Table Germany Apixaban Market Share by Type (2015 and 2016)
Table Germany Apixaban Sales by Application (2015 and 2016)
Table Germany Apixaban Market Share by Application (2015 and 2016)
Figure France Apixaban Sales and Growth Rate (2012-2017)
Figure France Apixaban Revenue and Growth Rate (2012-2017)
Figure France Apixaban Sales Price Trend (2012-2017)
Table France Apixaban Sales by Manufacturers (2015 and 2016)
Table France Apixaban Market Share by Manufacturers (2015 and 2016)
Table France Apixaban Sales by Type (2015 and 2016)
Table France Apixaban Market Share by Type (2015 and 2016)
Table France Apixaban Sales by Application (2015 and 2016)
Table France Apixaban Market Share by Application (2015 and 2016)
Figure UK Apixaban Sales and Growth Rate (2012-2017)
Figure UK Apixaban Revenue and Growth Rate (2012-2017)
Figure UK Apixaban Sales Price Trend (2012-2017)
Table UK Apixaban Sales by Manufacturers (2015 and 2016)
Table UK Apixaban Market Share by Manufacturers (2015 and 2016)
Table UK Apixaban Sales by Type (2015 and 2016)
Table UK Apixaban Market Share by Type (2015 and 2016)
Table UK Apixaban Sales by Application (2015 and 2016)
Table UK Apixaban Market Share by Application (2015 and 2016)
Figure Russia Apixaban Sales and Growth Rate (2012-2017)
Figure Russia Apixaban Revenue and Growth Rate (2012-2017)
Figure Russia Apixaban Sales Price Trend (2012-2017)
Table Russia Apixaban Sales by Manufacturers (2015 and 2016)
Table Russia Apixaban Market Share by Manufacturers (2015 and 2016)
Table Russia Apixaban Sales by Type (2015 and 2016)
Table Russia Apixaban Market Share by Type (2015 and 2016)
Table Russia Apixaban Sales by Application (2015 and 2016)
Table Russia Apixaban Market Share by Application (2015 and 2016)
Figure Italy Apixaban Sales and Growth Rate (2012-2017)
Figure Italy Apixaban Revenue and Growth Rate (2012-2017)
Figure Italy Apixaban Sales Price Trend (2012-2017)
Table Italy Apixaban Sales by Manufacturers (2015 and 2016)
Table Italy Apixaban Market Share by Manufacturers (2015 and 2016)
Table Italy Apixaban Sales by Type (2015 and 2016)
Table Italy Apixaban Market Share by Type (2015 and 2016)
Table Italy Apixaban Sales by Application (2015 and 2016)
Table Italy Apixaban Market Share by Application (2015 and 2016)
Figure Spain Apixaban Sales and Growth Rate (2012-2017)
Figure Spain Apixaban Revenue and Growth Rate (2012-2017)
Figure Spain Apixaban Sales Price Trend (2012-2017)
Table Spain Apixaban Sales by Manufacturers (2015 and 2016)
Table Spain Apixaban Market Share by Manufacturers (2015 and 2016)
Table Spain Apixaban Sales by Type (2015 and 2016)
Table Spain Apixaban Market Share by Type (2015 and 2016)
Table Spain Apixaban Sales by Application (2015 and 2016)
Table Spain Apixaban Market Share by Application (2015 and 2016)
Figure Benelux Apixaban Sales and Growth Rate (2012-2017)
Figure Benelux Apixaban Revenue and Growth Rate (2012-2017)
Figure Benelux Apixaban Sales Price Trend (2012-2017)
Table Benelux Apixaban Sales by Manufacturers (2015 and 2016)
Table Benelux Apixaban Market Share by Manufacturers (2015 and 2016)
Table Benelux Apixaban Sales by Type (2015 and 2016)
Table Benelux Apixaban Market Share by Type (2015 and 2016)
Table Benelux Apixaban Sales by Application (2015 and 2016)
Table Benelux Apixaban Market Share by Application (2015 and 2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer, Inc. (US) Apixaban Sales Market Share (2012-2017)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Healthcare AG (Germany) Apixaban Sales Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. (UK) Apixaban Sales Market Share (2012-2017)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim (Germany) Apixaban Sales Market Share (2012-2017)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi S.A. (France) Apixaban Sales Market Share (2012-2017)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott India Limited (India) Apixaban Sales Market Share (2012-2017)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aspen Holdings (South Africa) Apixaban Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Company (US) Apixaban Sales Market Share (2012-2017)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Inc. (US) Apixaban Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Apixaban
Figure Manufacturing Process Analysis of Apixaban
Figure Apixaban Industrial Chain Analysis
Table Raw Materials Sources of Apixaban Major Manufacturers in 2015
Table Major Buyers of Apixaban
Table Distributors/Traders List
Figure Germany Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure Germany Apixaban Revenue and Growth Rate Forecast (2017-2021)
Figure France Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure France Apixaban Revenue and Growth Rate Forecast (2017-2021)
Figure UK Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure UK Apixaban Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure Russia Apixaban Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure Italy Apixaban Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure Spain Apixaban Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Apixaban Revenue and Growth Rate Forecast (2017-2021)
Table Europe Apixaban Sales Forecast by Type (2017-2021)
Table Europe Apixaban Sales Forecast by Application (2017-2021)